Data / Research funding / Ohio / University of Toledo Health Sci Campus
University of Toledo Health Sci Campus: 73 NIH awards ($56.4M) and 3 NSF awards ($1.4M), fiscal years 2021 to 2026
University of Toledo Health Sci Campus in Toledo, OH is funded under 73 NIH awards ($56.4M) and 3 NSF awards ($1.4M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- M9ACC5DQCNL6
- State
- Ohio
Awards
76 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| PPARG regulates osteocyte bioenergetics and function during aging | NIH | National Institute on Aging | 2021 to 2025 | $3,381,593 | September 30, 2021 | May 31, 2027 | LECKA-CZERNIK, BEATA ANNA | reporter.nih.gov |
| Cross platform analysis of drug targets and toxicity of bath salts | NIH | National Institute on Drug Abuse | 2022 to 2025 | $2,538,810 | September 15, 2022 | June 30, 2027 | SCHIEFER, ISAAC T | reporter.nih.gov |
| Targeting eIF4A1 in drug-resistant breast cancer stem-like cells | NIH | National Cancer Institute | 2022 to 2025 | $2,500,438 | August 9, 2022 | July 31, 2027 | RAMAN, DAYANIDHI | reporter.nih.gov |
| Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadism | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,148,846 | May 1, 2022 | January 31, 2027 | HILL, JENNIFER WOOTTON | reporter.nih.gov |
| Neural mechanisms of host-microbiota interaction in hypertension: a potential for bio-electronic medicine | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,796,420 | June 1, 2021 | September 3, 2024 | ZUBCEVIC, JASENKA | reporter.nih.gov |
| Novel GLT-1 activators for the treatment of alcohol dependence: preclinical studies | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $1,703,140 | September 1, 2022 | May 31, 2027 | SARI, YOUSSEF | reporter.nih.gov |
| Cofilin Signaling in Hemorrhagic Stroke | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,560,785 | June 15, 2020 | March 31, 2026 | SHAH, ZAHOOR AHMAD | reporter.nih.gov |
| Understanding the proviral role for TRAF6 interaction with the viral protease in flavivirus replication and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,545,000 | May 15, 2020 | April 30, 2025 | TAYLOR, ROGER TRAVIS | reporter.nih.gov |
| Conjugated bile acids as nutritionally re-programmable antihypertensive metabolites | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,530,450 | July 16, 2024 | May 31, 2028 | JOE, BINA | reporter.nih.gov |
| Investigation of active kinome networks in Alzheimer's dementia. | NIH | National Institute on Aging | 2024 to 2025 | $1,529,808 | September 15, 2024 | May 31, 2029 | MCCULLUMSMITH, ROBERT E | reporter.nih.gov |
| Engineering Exosome for Pancreatic Cancer Targeting Therapies | NIH | National Cancer Institute | 2023 to 2025 | $1,510,439 | September 21, 2023 | August 31, 2028 | LIU, SHI-HE | reporter.nih.gov |
| Pre and post-synaptic pathways underlying the stress response in the adrenal medulla | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,465,325 | March 1, 2022 | December 31, 2026 | ANANTHARAM, ARUN | reporter.nih.gov |
| Role of GSK3beta in diabetic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,346,004 | September 9, 2022 | May 31, 2027 | GONG, RUJUN | reporter.nih.gov |
| Training in Molecular and translational Cell Dynamics | NIH | National Institute of General Medical Sciences | 2022 to 2024 | $1,322,740 | May 1, 2022 | April 30, 2025 | OSMAN, MAHASIN A. | reporter.nih.gov |
| Building a kidney monitoring panel to guide therapy in resistant hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,311,757 | July 1, 2024 | June 30, 2028 | GUPTA, RAJESH | reporter.nih.gov |
| Role of neutrophil extracellular traps (NETs) in Inflammatory bowel disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,279,974 | February 15, 2023 | January 31, 2027 | VIJAY-KUMAR, MATAM | reporter.nih.gov |
| The role of platelets in protection against oral candidiasis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,236,861 | January 1, 2019 | December 31, 2024 | CONTI, HEATHER RAQUEL | reporter.nih.gov |
| Dissecting Molecular Mechanisms of Tumor-Induced Myeloid-Mediated Immune Suppression in Triple-Negative Breast Cancer | NIH | National Cancer Institute | 2024 to 2025 | $1,130,019 | September 13, 2024 | August 31, 2029 | ZHANG, JIANMIN | reporter.nih.gov |
| Gut-brain axis in Parkinson's disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,093,005 | July 1, 2020 | June 30, 2027 | SUBRAMANIAN, THYAGARAJAN | reporter.nih.gov |
| Integration of Leukotriene and Prostaglandin Receptor Signaling in Mast cell Activation and Pulmonary Inflammation during Asthma | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,059,387 | February 20, 2019 | January 31, 2025 | PARUCHURI, SAILAJA | reporter.nih.gov |
| Dissecting catalytic and regulatory functions of nonsegmented negative strandRNA viral polymerases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,042,875 | June 1, 2020 | May 31, 2025 | OGINO, TOMOAKI | reporter.nih.gov |
| Effective targeting survivin dimerization interface with small molecule inhibitors | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,035,504 | September 1, 2018 | May 31, 2025 | LIU, JASMINE JINGYUAN | reporter.nih.gov |
| Influence of bone microenvironment on drug resistance in prostate cancer bone metastasis | NIH | National Cancer Institute | 2022 to 2024 | $1,028,449 | April 19, 2019 | December 31, 2025 | LI, XIAOHONG | reporter.nih.gov |
| Mechanical Control of Coronary Angiogenesis in Myocardial Adaptation to Ischemia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $952,130 | September 19, 2019 | July 31, 2025 | THODETI, CHARLES K | reporter.nih.gov |
| Anti-inflammatory functions for non-transcriptional IRF3 | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $935,898 | February 8, 2021 | January 31, 2024 | CHATTOPADHYAY, SAURABH | reporter.nih.gov |
| Stress Response Mechanisms in Vibrio | NSF | Division of Molecular and Cellular Biosciences | 2022 | $800,000 | February 15, 2022 | January 31, 2026 | Jyl S Matson | nsf.gov |
| Determining role of 14-3-3zeta in IL-17A signaling | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $790,019 | June 10, 2024 | February 13, 2025 | CHAKRAVARTI, RITU | reporter.nih.gov |
| Development of Attenuated Furoxans as Novel Therapies for Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $772,500 | April 15, 2018 | January 31, 2025 | SCHIEFER, ISAAC T | reporter.nih.gov |
| YAP1, neointima formation, and blood pressure regulation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $747,000 | December 1, 2022 | November 30, 2026 | OSMAN, ISLAM | reporter.nih.gov |
| ATR Isomerization in Cellular Responses to UV Damage of DNA | NIH | National Cancer Institute | 2021 to 2022 | $746,117 | August 1, 2017 | July 31, 2024 | ZOU, YUE | reporter.nih.gov |
| Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift of HER2+ breast cancer | NIH | National Cancer Institute | 2021 to 2022 | $706,838 | March 4, 2020 | October 14, 2022 | FURUTA, SAORI | reporter.nih.gov |
| Molecular targeting the translational control axis in Wnt/beta-catenin signaling pathway | NIH | National Cancer Institute | 2021 to 2022 | $696,807 | August 1, 2017 | July 31, 2024 | ZHANG, JIAN-TING | reporter.nih.gov |
| Genetic, Epigenetic and Dietary Salt effects on Microbiota and Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 | $666,530 | July 10, 2018 | April 30, 2023 | JOE, BINA | reporter.nih.gov |
| Developmental pyrethroid exposure in the prairie vole as a model of environmental risk for autism | NIH | National Institute of Environmental Health Sciences | 2025 | $605,550 | May 1, 2025 | February 28, 2030 | BURKETT, JAMES | reporter.nih.gov |
| Novel cysteinyl leukotriene receptor signaling in regulating cellular, and molecular events in lung inflammation | NIH | National Heart, Lung, and Blood Institute | 2025 | $579,309 | June 9, 2025 | February 28, 2029 | PARUCHURI, SAILAJA | reporter.nih.gov |
| Serotonin-mediated reorganization of the adolescent medial prefrontal cortex | NIH | National Institute of Mental Health | 2025 | $545,759 | June 1, 2025 | May 31, 2027 | NINAN, IPE | reporter.nih.gov |
| Molecular basis and targeting of FASN in expanding PARPi utility for TNBC | NIH | National Cancer Institute | 2025 | $524,419 | February 1, 2025 | January 31, 2030 | ZHANG, JIAN-TING | reporter.nih.gov |
| Collaborative Research: SCH: CLINICAL ADAPTIVE PERFORMANCE ENHANCEMENT THROUGH HUMAN-AI TEAMING (CAPE-HAT) | NSF | CSE - Core Programs | 2024 | $519,645 | September 1, 2024 | August 31, 2028 | Scott M Pappada | nsf.gov |
| Behavioral and Neurological Effects of Developmental Pyrethroid Exposure in Rodents | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $498,000 | May 1, 2020 | November 30, 2023 | BURKETT, JAMES | reporter.nih.gov |
| A transcription-independent role of HSF1 in tumorigenesis via suppression of AMPK | NIH | National Cancer Institute | 2021 to 2023 | $485,886 | July 1, 2021 | June 30, 2025 | SU, KUO-HUI | reporter.nih.gov |
| Novel antiviral mechanisms of the interferon system | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $450,507 | May 25, 2022 | April 30, 2027 | CHATTOPADHYAY, SAURABH | reporter.nih.gov |
| Structure and function of Borna disease virus polymerase | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $445,199 | August 17, 2023 | July 31, 2025 | OGINO, TOMOAKI | reporter.nih.gov |
| Mechanistic tRNA modification affects to aging | NIH | National Institute on Aging | 2025 | $430,603 | November 15, 2024 | October 31, 2026 | PRESTWICH, ERIN G | reporter.nih.gov |
| A novel model to study COVID-19 and Hypertension | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $424,875 | June 14, 2021 | May 31, 2023 | JOE, BINA | reporter.nih.gov |
| Role of gut commensal Coprococcus comes in angiotensin-converting enzyme inhibitor resistant hypertension | NIH | National Institute on Aging | 2022 to 2023 | $424,875 | August 4, 2022 | April 30, 2025 | YANG, TAO | reporter.nih.gov |
| Zebrafish Screens to Identify Agents which Reverse the Effects of Synthetic Opioids | NIH | National Institute on Drug Abuse | 2023 to 2024 | $424,875 | April 1, 2023 | September 30, 2025 | SCHIEFER, ISAAC T | reporter.nih.gov |
| Developmental pyrethroid exposure in the Shank3 mutant prairie vole as a 2-hit model for neurodevelopmental disorder risk | NIH | National Institute of Environmental Health Sciences | 2024 | $421,047 | August 14, 2024 | July 31, 2026 | BURKETT, JAMES | reporter.nih.gov |
| A large sample machine learning network analysis of vertex cortical thickness measures for high resolution definition of PTSD related cortical structure abnormalities | NIH | National Institute of Mental Health | 2022 to 2023 | $411,527 | January 17, 2022 | December 31, 2025 | WANG, XIN | reporter.nih.gov |
| Using pre-pandemic baseline data in people with and without PTSD to study effects of the COVID-19 pandemic on mental health and brain emotion circuits | NIH | National Institute of Mental Health | 2022 to 2023 | $409,951 | March 3, 2022 | February 28, 2025 | WANG, XIN | reporter.nih.gov |
| The effect of SHANK3 mutation in transgenic prairie voles on natural social behaviors and genetic mechanisms | NIH | National Institute of Mental Health | 2022 to 2023 | $405,640 | January 1, 2022 | November 30, 2024 | BURKETT, JAMES | reporter.nih.gov |
| Targeting of eIF4A along with immunotherapy to overcome chemoresistance | NIH | National Cancer Institute | 2022 to 2023 | $393,647 | January 1, 2022 | December 31, 2024 | RAMAN, DAYANIDHI | reporter.nih.gov |
| Targeting FASN to eliminate metastatic breast cancer in the brain | NIH | National Cancer Institute | 2023 to 2024 | $386,425 | July 8, 2023 | June 30, 2025 | ZHANG, JIAN-TING | reporter.nih.gov |
| Control of Klebsiella capsule biosynthesis and attachment | NIH | National Institute of General Medical Sciences | 2023 | $386,250 | September 1, 2023 | July 31, 2024 | MIKE, LAURA ANZALDI | reporter.nih.gov |
| Counter regulatory mechanisms of cardiotonic steroids in cardio-renal syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 | $378,750 | April 1, 2017 | March 31, 2023 | KENNEDY, DAVID JOSEPH | reporter.nih.gov |
| Optogenetic and Chemogenetic Dissection of Cell Transplants | NIH | National Institute of Neurological Disorders and Stroke | 2022 | $361,165 | May 4, 2022 | April 30, 2025 | SUBRAMANIAN, THYAGARAJAN | reporter.nih.gov |
| The Melanocortinergic pathway inglomerular disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $351,936 | August 15, 2017 | May 31, 2024 | GONG, RUJUN | reporter.nih.gov |
| Acquisition of a FACSymphony S6 Sorter for the University of Toledo Flow Cytometry Core | NIH | Office of the Director, National Institutes of Health | 2024 | $350,000 | September 1, 2024 | August 31, 2025 | KALINOSKI, ANDREA LYNN | reporter.nih.gov |
| Interplay between Dietary Fiber and Gut Microbiota in Hepatocellular Carcinoma | NIH | National Cancer Institute | 2021 | $342,592 | July 1, 2017 | June 30, 2023 | VIJAY-KUMAR, MATAM | reporter.nih.gov |
| Enhancing chemotherapeutic efficacy in triple-negative breast cancer via DSTYK silence | NIH | National Cancer Institute | 2025 | $336,458 | April 1, 2025 | March 31, 2028 | JIANG, YONG | reporter.nih.gov |
| Targeting PI3K/BRD4 and Hedgehog Pathway in Alcohol Associated Liver Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $316,914 | July 11, 2024 | August 31, 2026 | KUMAR, VIRENDER | reporter.nih.gov |
| Cerebrovascular endothelial cilia in the pathogenesis and therapy of Alzheimer's disease | NIH | National Institute on Aging | 2023 to 2024 | $300,825 | February 1, 2023 | January 31, 2026 | ABOUALAIWI, WISSAM | reporter.nih.gov |
| Study of early brain alterations that predict development of chronic PTSD | NIH | National Institute of Mental Health | 2021 | $293,686 | April 28, 2021 | June 30, 2022 | WANG, XIN | reporter.nih.gov |
| Functional Genetic Analysis of Klebsiella pneumoniae Hypervirulence | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $268,720 | July 15, 2021 | August 31, 2023 | MIKE, LAURA ANZALDI | reporter.nih.gov |
| Investigating the long-term effects of prenatal circadian rhythm disruption on substance use-related disorders | NIH | National Institute on Drug Abuse | 2025 | $248,996 | February 15, 2022 | January 31, 2028 | DEPOY, LAUREN MARIE | reporter.nih.gov |
| Intrarenal Arteries Sense N-formyl Peptides Leading to Vascular Injury in Sepsis | NIH | National Institute of General Medical Sciences | 2021 | $188,736 | September 1, 2016 | July 31, 2021 | WENCESLAU, CAMILLA FERREIRA | reporter.nih.gov |
| Elucidating the Cardioprotective Role of Fetal-derived CD8+ T Cells During Viral-induced Myocarditis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $162,000 | September 1, 2025 | August 31, 2027 | HILT, ZACHARY T | reporter.nih.gov |
| SWI/SNF in ultraviolet radiation-induced chromatin alterations | NIH | National Institute of Environmental Health Sciences | 2025 | $156,250 | December 20, 2024 | November 30, 2026 | DE LA SERNA, IVANA L | reporter.nih.gov |
| TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer | NIH | National Cancer Institute | 2024 to 2025 | $127,327 | September 1, 2024 | December 31, 2025 | ZHANG, JIANMIN | reporter.nih.gov |
| AMPK localization, expression, and activity in Alzheimer's Disease | NIH | National Institute on Aging | 2022 to 2024 | $124,871 | September 1, 2022 | August 31, 2026 | HENKEL, NICHOLAS DANIEL | reporter.nih.gov |
| Autophagy regulates β-hydroxybutyrate synthesis to prevent hypertension-associated premature vascular aging | NIH | National Heart, Lung, and Blood Institute | 2021 | $109,840 | July 1, 2020 | December 31, 2021 | MCCARTHY, CAMERON | reporter.nih.gov |
| Inhalation Exposure to Aerosolized Cyanotoxins Worsens Pre-Existing Asthma via Activation of Granulocytic Inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $60,326 | August 27, 2021 | April 21, 2023 | BREIDENBACH, JOSHUA DAVID | reporter.nih.gov |
| Targeting Gut Microbiota Metabolites to Prevent Liver Cancer | NIH | National Cancer Institute | 2022 to 2023 | $53,505 | January 13, 2022 | January 14, 2023 | GOLONKA, RACHEL M. | reporter.nih.gov |
| I-Corps: Translation Potential of an Artificial Intelligence (AI)-Based Platform for Early Osteoporosis Risk Prediction | NSF | Pathways for Translation Section | 2026 | $50,000 | September 1, 2026 | August 31, 2027 | Ambalangodage C Jayasuriya | nsf.gov |
| Influence of arginine on Klebsiella pneumoniae mucoidy and pathogenesis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $39,066 | January 9, 2026 | RING, BROOKE | reporter.nih.gov | |
| PPARG regulates osteocyte bioenergetics and function during aging | NIH | National Institute on Aging | 2021 | $26,388 | August 1, 2021 | September 29, 2021 | LECKA-CZERNIK, BEATA ANNA | reporter.nih.gov |
| Formyl peptide receptor activation induces vascular plasticity and remodeling in hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 | $26,294 | January 15, 2021 | July 31, 2021 | WENCESLAU, CAMILLA FERREIRA | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $50,000 |
| 2025 | 27 | $12,174,902 | 0 | $0 |
| 2024 | 30 | $12,517,467 | 1 | $519,645 |
| 2023 | 33 | $10,436,959 | 0 | $0 |
| 2022 | 37 | $12,276,853 | 1 | $800,000 |
| 2021 | 28 | $8,984,276 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | July 12, 2027 | Not listed | Notice number printed on 2 awards here | |
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 11 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 11 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 11 awards here |
Topics of its NIH awards
- Neurosciences
- Genetics
- Cancer
- Brain Disorders
- Cardiovascular
- Infectious Diseases
- Aging
- Biotechnology
- Hypertension
- Behavioral and Social Science
- Digestive Diseases
- Basic Behavioral and Social Science
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.